Brevan Howard Capital Management LP Iovance Biotherapeutics, Inc. Transaction History
Brevan Howard Capital Management LP
- $17 Billion
- Q3 2025
A detailed history of Brevan Howard Capital Management LP transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 271,967 shares of IOVA stock, worth $671,758. This represents 0.0% of its overall portfolio holdings.
Number of Shares
271,967
Previous 361,803
24.83%
Holding current value
$671,758
Previous $622,000
5.14%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding IOVA
# of Institutions
292Shares Held
219MCall Options Held
2.41MPut Options Held
1.7M-
Mhr Fund Management LLC New York, NY29MShares$71.5 Million10.25% of portfolio
-
Vanguard Group Inc Valley Forge, PA24.1MShares$59.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$52.4 Million0.0% of portfolio
-
State Street Corp Boston, MA13.3MShares$32.9 Million0.0% of portfolio
-
Invenomic Capital Management LP Boston, MA10.5MShares$26 Million1.15% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $390M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...